Associated Papers
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
Kohli M et al.
Ebiomedicine, 2020
32268276 (PubMed )
Supplement: mmc5.xlsx › cfDNA_SNV
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
Scherrer AU et al.
Plos One, 2012
Computational mutation scanning and drug resistance mechanisms of HIV-1 protease inhibitors.
Hao GF et al.
The Journal of Physical Chemistry. B, 2010
Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.
Palma AC et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 2010
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
Vergani B et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 2008
Select a paper to view details